Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
FEBS Letters|December 16, 2014
Osteopontin-integrin α(v)β(3) axis is crucial for 5-fluorouracil resistance in oral squamous cell carcinomaTakuya Nakamura, Satoru Shinriki, Hirofumi Jono, et al.
British Journal of Cancer|October 14, 2016
IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinomaYuichiro Matsuoka, Hideki Nakayama, Ryoji Yoshida, et al.
Biochemistry and Biophysics Reports|September 30, 2021
miR-30a attenuates drug sensitivity to 5-FU by modulating cell proliferation possibly by downregulating cyclin E2 in oral squamous cell carcinomaKenta Kawahara, Masashi Nagata, Ryoji Yoshida, et al.
Cancer Medicine|February 21, 2025
Robust HPV-16 Detection Workflow for Formalin-Fixed Cancer Tissue and Its Application for Oral Squamous Cell CarcinomaShizuka Morodomi, Akiyuki Hirosue, Akhinur Rahman, et al.
Cancers|February 26, 2020
Enhanced Expression of IGFBP-3 Reduces Radiosensitivity and Is Associated with Poor Prognosis in Oral Squamous Cell CarcinomaJunki Sakata, Akiyuki Hirosue, Ryoji Yoshida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2014
Phase II clinical trial of multiple peptide vaccination for advanced head and neck cancer patients revealed induction of immune responses and improved OSYoshihiro Yoshitake, Daiki Fukuma, Akira Yuno, et al.
Cancer Immunology, Immunotherapy : CII|January 19, 2022
Naringenin potentiates anti-tumor immunity against oral cancer by inducing lymph node CD169-positive macrophage activation and cytotoxic T cell infiltrationSho Kawaguchi, Kenta Kawahara, Yukio Fujiwara, et al.
Cancer Cell International|November 15, 2022
Potential use of EGFR-targeted molecular therapies for tumor suppressor CYLD-negative and poor prognosis oral squamous cell carcinoma with chemoresistanceAyumi Kanemaru, Satoru Shinriki, Mimi Kai, et al.
Journal of Extracellular Vesicles|December 11, 2021
Extracellular vesicles derived from radioresistant oral squamous cell carcinoma cells contribute to the acquisition of radioresistance via the miR-503-3p-BAK axisKeisuke Yamana, Junki Inoue, Ryoji Yoshida, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 21, 2023
FOXM1-Mediated Regulation of Reactive Oxygen Species and Radioresistance in Oral Squamous Cell Carcinoma CellsHisashi Takeshita, Ryoji Yoshida, Junki Inoue, et al.
Pageof 7